Mink Therapeutics Inc

Biotech Stocks Healthcare Stocks

$10.51

-0.54 (-4.89%)

As of May 16, 2:20 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +90.0% upside

Low Target $17.96

Average Target $19.97

High Target $26.10

Current Price $10.51

Current
$10.51

Target
$19.97

$17.96 $19.97 avg $26.10

Scenario Analysis

Bear Case

$17.96

70.9%

Low target

Base Case

$19.97

+90.0%

Avg target

Bull Case

$26.10

+148.3%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$76.00

-86.2% from high

52-Week Low

$6.65

+58.1% from low

Target vs 52W High

$19.97

-73.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%